Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUBA-itraconazole vs Conventional Itraconazole in Endemic Mycoses
NCT03572049Phase 3Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Sep 2018
- Primary completion
- May 2021
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of SUBA itraconazole in histoplasmosis, coccidioidomycosis, paracoccidioidomycosis (PCM), blastomycosis, sporotrichosis, sponsored by University of Alabama at Birmingham. Started Sep 2018; status: completed.
02
Drugs
SUBA itraconazole
03
Conditions
histoplasmosiscoccidioidomycosisparacoccidioidomycosis (PCM)blastomycosissporotrichosis
Beyond the preview
Go deeper on NCT03572049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03572049.